SCHEMBL23745627

SCHEMBL23745627

N[C@H]1CC[C@H](NC(=O)CC(c2cccc(F)c2)c2cn(CC3CCCCC3)c3ccccc23)CC1

nearest known ligand 0.42

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CNR1 P21554 3/20 0.42
ALDH1A1 P00352 2/20 0.40
RXFP1 Q9HBX9 1/20 0.40
ICMT O60725 1/20 0.40
IDO1 P14902 2/20 0.39
KMT2A Q03164 1/20 0.39
LMNA P02545 2/20 0.39
MAPT P10636 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
CCR1 P32246 1/20 0.38
TPSAB1 Q15661 1/20 0.38
CYP3A4 P08684 1/20 0.38
HPGD P15428 1/20 0.38
CYP2C19 P33261 1/20 0.38
RAB9A P51151 1/20 0.38
PTGDR2 Q9Y5Y4 1/20 0.38
USP2 O75604 1/20 0.38
CNR2 P34972 1/20 0.37
IDH1 O75874 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL23721910 0.99 CNR1 (0.41) CNR1ALDH1A1RXFP1ICMTIDO1
SCHEMBL23745798 0.92 CNR1 (0.47) CNR1ALDH1A1IDO1KMT2ALMNA
Hydrochloric Acid SCHEMBL23721975 0.91 CNR1 (0.46) CNR1ALDH1A1IDO1KMT2ALMNA
SCHEMBL23745582 0.90 CNR1 (0.42) CNR1ALDH1A1RXFP1IDO1KMT2A
SCHEMBL23745532 0.90 CNR1 (0.42) CNR1ALDH1A1ICMTKMT2ALMNA
SCHEMBL23745643 0.90 CNR1 (0.42) CNR1ALDH1A1RXFP1ICMTIDO1
SCHEMBL23745594 0.90 CNR1 (0.42) CNR1ALDH1A1ICMTKMT2ALMNA
SCHEMBL23745577 0.90 CNR1 (0.42) CNR1ALDH1A1ICMTKMT2ALMNA
SCHEMBL23745575 0.90 CNR1 (0.42) CNR1ALDH1A1ICMTKMT2ALMNA
SCHEMBL23745839 0.90 CNR1 (0.42) CNR1ALDH1A1IDO1KMT2ALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210246115-A1 ANTI-INFECTIVE HETEROCYCLIC COMPOUNDS AND USES THEREOF BIOIMICS AB (SE) 2021-08-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210246115-A1 ANTI-INFECTIVE HETEROCYCLIC COMPOUNDS AND USES THEREOF FDPS, FPR1, F12 CNR1 1651/4885ALDH1A1 1197/4885RXFP1 3856/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.